INTERNATIONAL PATENT: STEP PHARMA S.A.S. FILES APPLICATION FOR "CTPS1 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS"

GENEVA, Feb. 9 -- STEP PHARMA S.A.S. (101 rue de Sevres75272 Paris, Cedex 06) filed a patent application (PCT/EP2025/072221) for "CTPS1 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS" on Aug 01, 2025. With publication no. WO/2026/027753, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PARKER, Andrew (c/o Step Pharma S.A.S.101 rue de Sevres75272 Paris, Cedex 06), BEER, Philip (c/o Step Pharma S.A.S.101 rue de Sevres75272 Paris, Cedex 06)

Abstract: The invention provides, inter alia, a CTPS1 inhibitor for use...